Havent been following the story for a while. With management and board changes and cardio protection a now a big focus the FTO inhibition story is less visible to me. Can i tempt anyone to explain whether the lab/clinical trial process remains on track. Melanoma was an early target. As a bit of a tease: when i first started looking at this stock it showed promise as a cancer treatment of equal standing to standard of care in some setting but noted as being less damaging to heart. then that got de-emphasised as the FTO discovery took centre stage. Now the focus is cardio protection which feels more like the original story. I understand that cardio-protection could have broad application. But before cardio protection Wombat et al were talking about a drug that was bigger than Keytruda. Has the FTO opportunity been downgarded, pushed out delayed, seem less likely of scusses then a year ago. Has anything changed?
- Forums
- ASX - By Stock
- RAC
- Pillar 1 - FTO (new thread)
Pillar 1 - FTO (new thread), page-2364
-
- There are more pages in this discussion • 542 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $242.5M |
Open | High | Low | Value | Volume |
$1.46 | $1.50 | $1.43 | $62.91K | 43.17K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5700 | $1.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 591 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5700 | 1.430 |
3 | 13542 | 1.420 |
2 | 20700 | 1.410 |
1 | 3500 | 1.405 |
6 | 25737 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 591 | 1 |
1.500 | 7000 | 1 |
1.510 | 2408 | 1 |
1.540 | 10000 | 1 |
1.550 | 26171 | 3 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.46 |
  |
Change
-0.005 ( 0.23 %) |
|||
Open | High | Low | Volume | ||
$1.44 | $1.49 | $1.43 | 9034 | ||
Last updated 13.08pm 24/05/2024 ? |
Featured News
RAC (ASX) Chart |